Delivery Order SPE2DB22D3004-SPE2DB25FPS40

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,833.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,563,188,851 units of Methylphenidate 5 mg chewable tablets, a medication used in the treatment of ADHD. The contract has a firm fixed price and an ultimate completion date of December 28, 2023. This award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.68 firm-fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.74 Firm Fixed Price delivery order is for the supply of 4,556,483,775 units of methylphenidate 2.5 mg chewable tablets. The contract has an ultimate completion date of March 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,233.88 firm-fixed-price delivery order is for the supply of 4566758921 - Methylphenidate 5 mg Chew Tabs in 100-count bottles. The contract has a completion date of December 19, 2024 and was awarded on December 18, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Methylphenidate 2.5 mg chewable tablets in quantities of 100 to the Defense Logistics Agency (DLA). The $1,327.34 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 5, 2022. The contract has an ultimate completion date of January 6, 2022 and was not designated as a set-aside. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., has a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,207.38 firm fixed-price contract is for the delivery of 100-count bottles of 54 mg extended-release methylphenidate tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,087.71 firm fixed-price delivery order is for the supply of 100 count bottles of 36 mg extended-release Methylphenidate tablets. The award is not designated under any set-aside program. This order is fulfilled under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $8,219.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,739,444 units of 10 mg Methylphenidate chewable tablets. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.85 firm-fixed-price delivery order is for the supply of 4,566,357,645 units of Methylphenidate ER 27 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.63 firm fixed-price delivery order is for the supply of 4,566,355,250 tablets of Methylphenidate ER 27 mg, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPS40
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,086.69 Firm Fixed Price delivery order contract covers the supply of 4567403537 - Methylphenidate 2.5 mg Chewable Tablets in 100-count bottles.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, with no major subcontractors noted. This award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 6/1/25, 2:46 AM